337 related articles for article (PubMed ID: 33036598)
1. Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis.
Uno S; Asakura T; Morimoto K; Yoshimura K; Uwamino Y; Nishimura T; Hoshino Y; Hasegawa N;
BMC Pulm Med; 2020 Oct; 20(1):262. PubMed ID: 33036598
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.
Izumi K; Morimoto K; Hasegawa N; Uchimura K; Kawatsu L; Ato M; Mitarai S
Ann Am Thorac Soc; 2019 Mar; 16(3):341-347. PubMed ID: 30339468
[TBL] [Abstract][Full Text] [Related]
3. Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims data.
Ringshausen FC; Ewen R; Multmeier J; Monga B; Obradovic M; van der Laan R; Diel R
Int J Infect Dis; 2021 Mar; 104():398-406. PubMed ID: 33444748
[TBL] [Abstract][Full Text] [Related]
4. Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.
Henkle E; Hedberg K; Schafer S; Novosad S; Winthrop KL
Ann Am Thorac Soc; 2015 May; 12(5):642-7. PubMed ID: 25692495
[TBL] [Abstract][Full Text] [Related]
5. Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.
Hu C; Huang L; Cai M; Wang W; Shi X; Chen W
BMC Infect Dis; 2019 Sep; 19(1):764. PubMed ID: 31477038
[TBL] [Abstract][Full Text] [Related]
6. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
Tan Y; Su B; Shu W; Cai X; Kuang S; Kuang H; Liu J; Pang Y
BMC Pulm Med; 2018 Nov; 18(1):168. PubMed ID: 30413193
[TBL] [Abstract][Full Text] [Related]
8. Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.
Prevots DR; Marras TK; Wang P; Mange KC; Flume PA
Chest; 2021 Dec; 160(6):2042-2050. PubMed ID: 34314672
[TBL] [Abstract][Full Text] [Related]
9. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.
Eikani MS; Nugent M; Poursina A; Simpson P; Levy H
BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010.
Smith GS; Ghio AJ; Stout JE; Messier KP; Hudgens EE; Murphy MS; Pfaller SL; Maillard JM; Hilborn ED
J Infect; 2016 Jun; 72(6):678-686. PubMed ID: 26997636
[TBL] [Abstract][Full Text] [Related]
11. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities of nontuberculous mycobacteria infection in Korean adults: results from the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database.
Lee SW; Park Y; Kim S; Chung EK; Kang YA
BMC Pulm Med; 2022 Jul; 22(1):283. PubMed ID: 35870927
[TBL] [Abstract][Full Text] [Related]
13. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
14. Clinically refined epidemiology of nontuberculous mycobacterial pulmonary disease in South Korea: overestimation when relying only on diagnostic codes.
Park JH; Shin S; Kim TS; Park H
BMC Pulm Med; 2022 May; 22(1):195. PubMed ID: 35562714
[TBL] [Abstract][Full Text] [Related]
15. Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012-2016.
Zhang ZX; Cherng BPZ; Sng LH; Tan YE
BMC Infect Dis; 2019 May; 19(1):436. PubMed ID: 31101082
[TBL] [Abstract][Full Text] [Related]
16. Underlying host risk factors for nontuberculous mycobacterial lung disease.
Chan ED; Iseman MD
Semin Respir Crit Care Med; 2013 Feb; 34(1):110-23. PubMed ID: 23460011
[TBL] [Abstract][Full Text] [Related]
17. Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study.
Veziris N; Andréjak C; Bouée S; Emery C; Obradovic M; Chiron R
BMC Infect Dis; 2021 Nov; 21(1):1165. PubMed ID: 34789152
[TBL] [Abstract][Full Text] [Related]
18. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.
Kendall BA; Winthrop KL
Semin Respir Crit Care Med; 2013 Feb; 34(1):87-94. PubMed ID: 23460008
[TBL] [Abstract][Full Text] [Related]
19. Reduction in Expected Survival Associated With Nontuberculous Mycobacterial Pulmonary Disease.
Mourad A; Baker AW; Stout JE
Clin Infect Dis; 2021 May; 72(10):e552-e557. PubMed ID: 32856690
[TBL] [Abstract][Full Text] [Related]
20. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
Kwon YS; Daley CL; Koh WJ
Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
